Clinical trial
Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure, in a Regionally Defined General Population
NCT03513796 is registered in ClinicalTrials.gov with NHS Tayside as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure, in a Regionally Defined General Population
- Lead sponsor
- NHS Tayside
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 20, 2018
- Completion date
- February 16, 2020
- Enrollment
- 1,949 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.